Original Article

You have full text access to this OnlineOpen article

Mammography screening of women in their 40s†

Impact of changes in screening guidelines

  1. Lisa Calvocoressi PhD1,‡,*,
  2. Albert Sun MD, MPH2,
  3. Stanislav V. Kasl PhD1,
  4. Elizabeth B. Claus MD, PhD1,
  5. Beth A. Jones PhD, MPH1

Article first published online: 10 DEC 2007

DOI: 10.1002/cncr.23210

Issue

Cancer

Cancer

Volume 112, Issue 3, pages 473–480, 1 February 2008

Additional Information

How to Cite

Calvocoressi, L., Sun, A., Kasl, S. V., Claus, E. B. and Jones, B. A. (2008), Mammography screening of women in their 40s. Cancer, 112: 473–480. doi: 10.1002/cncr.23210

Author Information

  1. 1

    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut

  2. 2

    The Hospital of Central Connecticut at New Britain, New Britain, Connecticut

  1. ‡

    Fax: (203) 764-7010

*Department of Epidemiology and Public Health, Yale University School of Medicine, 200 College Street, New Haven, CT 06510

  1. †

    See Editorial, 458–60, this issue.

Publication History

  1. Issue published online: 18 JAN 2008
  2. Article first published online: 10 DEC 2007
  3. Manuscript Accepted: 22 AUG 2007
  4. Manuscript Revised: 17 AUG 2007
  5. Manuscript Received: 5 JUL 2007

Funded by

  • National Cancer Institute. Grant Number: RO1 CA70731
  • Agency for Healthcare Research and Quality. Grant Number: RO3 HS11603
  • National Cancer Institute. Grant Number: RO1 CA95560

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (100K)

REFERENCES

  • 1
    United States Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed. Washington, DC: Office of Disease Prevention and Health Promotion; 1996.
  • 2
    Leitch AM. Breast cancer screening: success amid conflict. Surg Oncol Clin N Am. 1999; 8: 657–672, vi.
  • 3
    National Institutes of Health Consensus Development Conference Statement: Breast Cancer Screening for Women Ages 40–49, January 21–23, 1997. National Institutes of Health Consensus Development Panel. J Natl Cancer Inst. 1997; 89: 1015–1026.
  • 4
    Wells J,Marshall P,Crawley B,Dickersin K. Newspaper reporting of screening mammography. Ann Intern Med. 2001; 135: 1029–1037.
  • 5
    Leitch AM,Dodd GD,Costanza M, et al. American Cancer Society guidelines for the early detection of breast cancer: update 1997. CA Cancer J Clin. 1997; 47: 150–153.
    Direct Link:
  • 6
    Taubes G. NCI reverses one expert panel, sides with another. Science. 1997; 276: 27–28.
  • 7
    Aiken LS,Jackson KM,Lapin A. Mammography screening for women under 50: women's response to medical controversy and changing practice guidelines. Womens Health. 1998; 4: 169–197.
  • 8
    Rimer BK,Halabi S,Strigo TS,Crawford Y,Lipkus IM. Confusion about mammography: prevalence and consequences. JWomens Health Gend Based Med. 1999; 8: 509–520.
  • 9
    Woloshin S,Schwartz LM,Byram SJ,Sox HC,Fischhoff B,Welch HG. Women's understanding of the mammography screening debate. Arch Intern Med. 2000; 160: 1434–1440.
  • 10
    Fishbein M,Triandis HC,Kanfer FH,Becker M,Middlestadt SE,Eichler A. Factors influencing behavior and behavior change. In: BaumA,RevensonTA,SingerJE, editors. Handbook of Health Psychology. Mahwah, New Jersey: Lawrence Erlbaum; 2001: 3–17.
  • 11
    Calvocoressi L,Kasl SV,Lee CH,Stolar M,Claus EB,Jones BA. A prospective study of perceived susceptibility to breast cancer and nonadherence to mammography screening guidelines in African American and White women ages 40 to 79 years. Cancer Epidemiol Biomarkers Prev. 2004; 13: 2096–2105.
  • 12
    Jones BA,Dailey A,Calvocoressi L, et al. Inadequate follow-up of abnormal screening mammograms: findings from the race differences in screening mammography process study (United States). Cancer Causes Control. 2005; 16: 809–821.
  • 13
    Jones BA,Reams K,Calvocoressi L,Dailey A,Kasl SV,Liston NM. Adequacy of communicating results from screening mammograms to African American and White women. Am J Public Health. 2007; 97: 531–538.
  • 14
    Bastani R,Marcus AC,Hollatz-Brown A. Screening mammography rates and barriers to use: a Los Angeles County survey. Prev Med. 1991; 20: 350–363.
  • 15
    Calnan M. The health belief model and participation in programmes for the early detection of breast cancer: a comparative analysis. Soc Sci Med. 1984; 19: 823–830.
  • 16
    Fajardo LL,Saint-Germain M,Meakem TJ3rd,Rose C,Hillman BJ. Factors influencing women to undergo screening mammography. Radiology. 1992; 184: 59–63.
  • 17
    Fine MK,Rimer BK,Watts P. Women's responses to the mammography experience. J Am Board Fam Pract. 1993; 6: 546–555.
  • 18
    Jones BA,Culler CS,Kasl SV,Calvocoressi L. Is variation in quality of mammographic services race linked? J Health Care Poor Underserved. 2001; 12: 113–126.
  • 19
    Lerman C,Rimer B,Trock B,Balshem A,Engstrom PF. Factors associated with repeat adherence to breast cancer screening. Prev Med. 1990; 19: 279–290.
  • 20
    Stein JA,Fox SA,Murata PJ,Morisky DE. Mammography usage and the health belief model. Health Educ Q. 1992; 19: 447–462.
  • 21
    Zapka JG,Harris DR,Stoddard AM,Costanza ME. Validity and reliability of psychosocial factors related to breast cancer screening. Eval Health Prof. 1991; 14: 356–367.
  • 22
    Achat H,Close G,Taylor R. Who has regular mammograms? Effects of knowledge, beliefs, socioeconomic status, and health-related factors. Prev Med. 2005; 41: 312–320.
  • 23
    Bhosle M,Samuel S,Vosuri V,Paskett E,Balkrishnan R. Physician and patient characteristics associated with outpatient breast cancer screening recommendations in the United States: analysis of the National Ambulatory Medical Care Survey Data 1996–2004. Breast Cancer Res Treat. 2007; 103: 53–59.
  • 24
    Bobo JK,Shapiro JA,Schulman J,Wolters CL. On-schedule mammography rescreening in the National Breast and Cervical Cancer Early Detection Program. Cancer Epidemiol Biomarkers Prev. 2004; 13: 620–630.
  • 25
    Carney PA,Harwood BG,Weiss JE,Eliassen MS,Goodrich ME. Factors associated with interval adherence to mammography screening in a population-based sample of New Hampshire women. Cancer. 2002; 95: 219–227.
    Direct Link:
  • 26
    Champion VL. Compliance with guidelines for mammography screening. Cancer Detect Prev. 1992; 16: 253–258.
  • 27
    Clemow L,Costanza ME,Haddad WP, et al. Underutilizers of mammography screening today: characteristics of women planning, undecided about, and not planning a mammogram. Ann Behav Med. 2000; 22: 80–88.
  • 28
    Elwood M,McNoe B,Smith T,Bandaranayake M,Doyle TC. Once is enough—why some women do not continue to participate in a breast cancer screening programme. N Z Med J. 1998; 111: 180–183.
  • 29
    Falkenberry SS,Legare RD. Risk factors for breast cancer. Obstet Gynecol Clin North Am. 2002; 29: 159–172.
  • 30
    Halabi S,Skinner CS,Samsa GP,Strigo TS,Crawford YS,Rimer BK. Factors associated with repeat mammography screening. J Fam Pract. 2000; 49: 1104–1112.
  • 31
    Hitchcock JL,Steckevicz MJ,Thompson WD. Screening mammography: factors associated with adherence to recommended age/frequency guidelines. Womens Health. 1995; 1: 221–235.
  • 32
    Lee JR,Vogel VG. Who uses screening mammography regularly? Cancer Epidemiol Biomarkers Prev. 1995; 4: 901–906.
  • 33
    Marshall G. A comparative study of re-attenders and non-re-attenders for second triennial National Breast Screening Programme appointments. J Public Health Med. 1994; 16: 79–86.
  • 34
    Montano DE,Thompson B,Taylor VM,Mahloch J. Understanding mammography intention and utilization among women in an inner city public hospital clinic. Prev Med. 1997; 26: 817–824.
  • 35
    Orton M,Fitzpatrick R,Fuller A,Mant D,Mlynek C,Thorogood M. Factors affecting women's response to an invitation to attend for a second breast cancer screening examination. Br J Gen Pract. 1991; 41: 320–322.
  • 36
    Ostbye T,Greenberg GN,Taylor DHJr,Lee AM. Screening mammography and Pap tests among older American women 1996–2000: results from the Health and Retirement Study (HRS) and Asset and Health Dynamics Among the Oldest Old (AHEAD). Ann Fam Med. 2003; 1: 209–217.
  • 37
    Pearlman DN,Rakowski W,Ehrich B,Clark MA. Breast cancer screening practices among black, Hispanic, and white women: reassessing differences. Am J Prev Med. 1996; 12: 327–337.
  • 38
    Rakowski W,Breen N,Meissner H, et al. Prevalence and correlates of repeat mammography among women aged 55-79 in the Year 2000 National Health Interview Survey. Prev Med. 2004; 39: 1–10.
  • 39
    Rimer BK,Trock B,Engstrom PF,Lerman C,King E. Why do some women get regular mammograms? Am J Prev Med. 1991; 7: 69–74.
  • 40
    Strzelczyk JJ,Dignan MB. Disparities in adherence to recommended followup on screening mammography: interaction of sociodemographic factors. Ethn Dis. 2002; 12: 77–86.
  • 41
    Wee CC,McCarthy EP,Davis RB,Phillips RS. Obesity and breast cancer screening. J Gen Intern Med. 2004; 19: 324–331.
    Direct Link:
  • 42
    Rosenstock IM. Why people use health services. Milbank Mem Fund Q. 1966; 44( 3 suppl): 94–127.
  • 43
    Rosenstock IM. Historical origins of the Health Belief Model. Health Educ Monogr. 1974; 2: 328–335.
  • 44
    Wallston BD,Wallston KA. Locus of control and health: a review of the literature. Health Educ Monogr. 1978; 6: 107–117.
  • 45
    Wallston BS,Wallston KA,Kaplan GD,Maides SA. Development and validation of the health locus of control (HLC) scale. J Consult Clin Psychol. 1976; 44: 580–585.
  • 46
    Wallston KA,Wallston BS,DeVellis R. Development of the Multidimensional Health Locus of Control (MHLC) Scales. Health Educ Monogr. 1978; 6: 160–170.
  • 47
    Andersen MR,Smith R,Meischke H,Bowen D,Urban N. Breast cancer worry and mammography use by women with and without a family history in a population-based sample. Cancer Epidemiol Biomarkers Prev. 2003; 12: 314–320.
  • 48
    Miller AM,Champion VL. Mammography in older women: one-time and three-year adherence to guidelines. Nurs Res. 1996; 45: 239–245.
  • 49
    Miller AM,Champion VL. Attitudes about breast cancer and mammography: racial, income, and educational differences. Women Health. 1997; 26: 41–63.
  • 50
    Berry DA. Screening mammography for women in their forties. Breast Dis. 1998; 10: 23–32.
  • 51
    Berry DA. Benefits and risks of screening mammography for women in their forties: a statistical appraisal. J Natl Cancer Inst. 1998; 90: 1431–1439.
  • 52
    Fletcher SW. Whither scientific deliberation in health policy recommendations? Alice in the Wonderland of breast-cancer screening. N Engl J Med. 1997; 336: 1180–1183.
  • 53
    Schwartz LM,Woloshin S,Fowler FJJr,Welch HG. Enthusiasm for cancer screening in the United States. JAMA. 2004; 291: 71–78.
  • 54
    Morton E,Tambor E,Rimer BK,Tessaro I,Farrell D,Siegler IC. Impact of National Cancer Institute revised mammography screening guidelines on women 40–49. Womens Health Issues. 1996; 6: 246–254.
  • 55
    Klabunde CN,O'Malley MS,Kaluzny AD. Physicians' reactions to change in recommendations for mammography screening. Am J Prev Med. 1997; 13: 432–438.
  • 56
    Slanetz PJ,Moore RH,Hulka CA, et al. Screening mammography: effect of national guidelines on current physician practice. Radiology. 1997; 203: 335–338.
  • 57
    Schwartz LM,Woloshin S. News media coverage of screening mammography for women in their 40s and tamoxifen for primary prevention of breast cancer. JAMA. 2002; 287: 3136–3142.
  • 58
    Blanchard K,Colbert JA,Puri D, et al. Mammographic screening: patterns of use and estimated impact on breast carcinoma survival. Cancer. 2004; 101: 495–507.
    Direct Link:
  • 59
    Carney PA,Goodrich ME,Mackenzie T, et al. Utilization of screening mammography in New Hampshire: a population-based assessment. Cancer. 2005; 104: 1726–1732.
    Direct Link:
  • 60
    Cronin KA,Yu B,Krapcho M, et al. Modeling the dissemination of mammography in the United States. Cancer Causes Control. 2005; 16: 701–712.
  • 61
    Berry DA,Cronin KA,Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005; 353: 1784–1792.
  • 62
    Berry DA,Inoue L,Shen Y, et al. Modeling the impact of treatment and screening on U.S. breast cancer mortality: a Bayesian approach. J Natl Cancer Inst Monogr. 2006: 30–36.
  • 63
    Michaelson J,Satija S,Moore R, et al. The pattern of breast cancer screening utilization and its consequences. Cancer. 2002; 94: 37–43.
    Direct Link:
  • 64
    Michaelson JS,Satija S,Kopans D, et al. Gauging the impact of breast carcinoma screening in terms of tumor size and death rate. Cancer. 2003; 98: 2114–2124.
    Direct Link:
  • 65
    White E,Miglioretti DL,Yankaskas BC, et al. Biennial versus annual mammography and the risk of late-stage breast cancer. J Natl Cancer Inst. 2004; 96: 1832–1839.
  • 66
    Olsen O,Gotzsche PC. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2001: CD001877.
  • 67
    Olsen O,Gotzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet. 2001; 358: 1340–132. Erratum in: Lancet.2006;367:474.
  • 68
    Armstrong K,Moye E,Williams S,Berlin JA,Reynolds EE. Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians. Ann Intern Med. 2007; 146: 516–526.
  • 69
    Qaseem A,Snow V,Sherif K,Aronson M,Weiss KB,Owens DK; Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Screening mammography for women 40 to 49 years of age: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2007; 146: 511–515.
  • 70
    Saslow D,Boetes C,Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007; 57: 75–89. Erratum in: CA Cancer J Clin.2007;57:185.
    Direct Link:
View Full Article (HTML) Get PDF (100K)